The microsite is supported BY.

Highlights

Professional article
View Post

Special “GENETIC INSTABILITY”

In the special “GENETIC INSTABILITY” of Swiss Oncology in Motion, Prof. Dr. med. Viola Heinzelmann-Schwarz (University Hospital Basel), Prof. Dr. med. Jens Huober (Canton Hospital St. Gallen), PD Dr. med. Aurelius Omlin (OnkoZentrum Zürich), Prof. Dr. med. Dr. phil. Andreas Wicki (University Hospital Zurich) and Prof. Dr. med. Wolfram Jochum (Cantonal Hospital St. Gallen) discussed the role of genetic instability in various tumor types, in particular ovarian and endometrial carcinomas, breast carcionoma, GI tumors, and prostate, urothelial, and renal cell carcinomas, and how it influences treatment options. The discussion will be led by Prof. em. Richard Herrmann, MD, Basel, moderated…. This content can only be access by registered users. Log In Register
View Post

Special immunotherapy for cancer

Immunotherapy is about to revolutionize cancer treatment. That’s why it’s important to stay up to date in this rapidly changing field. With the current new Special Immunotherapies in Cancer from Swiss Oncology in Motion, you will receive a brief overview of the basics from Sacha Rothschild, MD. Afterwards, under the moderation of Prof. em. Richard Herrmann PD Dr. med. Richard Cathomas, Kantonsspital Chur, Dr. med. Ioannis Metaxas, Kantonsspital Thurgau, Dr. med. Berna Özdemir, Inselspital Bern and PD Dr. med. Dr. phil. Sacha Rothschild, University Hospital Basel the most relevant aspects for clinic and practice…. This content can only be access by registered users. Log In Register
View Post

Ovarian Cancer Module

Around 600 women are affected by ovarian cancer in Switzerland every year. Due to the non-specific symptoms, the disease is often only diagnosed at an advanced stage and most patients suffer a relapse. The Ovarian Cancer module of Swiss Oncology in Motion includes articles by Prof. em. Dr. med. Richard Herrmann moderated presentations by Dr. med. Dr. sc. nat. Anita Wolfer (Lausanne), Prof. Andreas Günthert (Lucerne) and PD Marcus Vetter (Basel). The ovarian cancer module was updated in June 2022.  … This content can only be access by registered users. Log In Register
View Post

Pancreatic Cancer Module

The Pancreatic Cancer module of Swiss Oncology in Motion includes articles by Prof. em. Richard Herrmann, MD, moderated presentations by Raphaël Delaloye, MD, (Department of Oncology, University Hospital Basel), PD Sara De Dosso, MD, (Instituto Oncologico della Svizzera Italiana (IOSI), Bellinzona Universita della Svizzera Italiana (USI), Lugano), and Alexander Siebenhüner, MD, (Oncology and Hematology, Kantonsspital Schaffhausen). You can get an overview of key information on incidence and epidemiology, pathology and molecular biology (including common genetic mutations), as well as diagnosis and available treatment options and corresponding study data…. This content can only be access by registered users. Log In Register
View Post

Acute Myeloid Leukemia Module

After many years without noticeable therapeutic progress, a number of new treatment options for acute myeloid leukemia have recently become available that could improve the situation for those affected. Prof. em. Richard Herrmann, MD, speaks in the Acute Myeloid Leukemia module of Swiss Oncology in Motion with Prof. Mario Bargetzi, MD (Kantonsspital Aarau), Rouven Müller, MD (USZ Zurich) and Prof. Georg Stüssi, MD (IOSI, Ticino)…. This content can only be access by registered users. Log In Register
View Post

Module Prostate Cancer

Treatment options for prostate cancer have evolved rapidly over the past two years, with advances across the spectrum of disease stages. Prof. em. Richard Herrmann, MD, speaks with Tobias Gross, MD (Inselspital Bern), Marie-Laure Amram, MD (Hirslanden) and Richard Cathomas, MD (Kantonsspital Graubünden) in the Swiss Oncology in Motion module on prostate cancer…. This content can only be access by registered users. Log In Register
View Post

Module: COVID-19 and oncology patients

There are no evidence-based recommendations for the management of tumor patients in corona crisis. The procedure is based worldwide on rational considerations and analogies. Through careful observations and exchange of information, we can learn every day and gradually optimize this approach. The expert panel* “COVID-19 and oncological patients” is intended to inform you about the current state of knowledge and to give you ideas for your own professional everyday life…. This content can only be access by registered users. Log In Register
View Post

Swiss Oncology in Motion: Video-based online training courses

Educational films in various modules for medical oncologists, hematologists and oncology specialists. Oncology is on the move – research is advancing rapidly and new insights into biology and therapy are constantly being gained. On the Swiss Oncology in Motion platform, relevant oncology topics are presented in modules with three expert presentations each as video training including CME questions…. This content can only be access by registered users. Log In Register
View Post

Chronic Lymphocytic Leukemia Module

The Chronic Lymphocytic Leukemia module of Swiss Oncology in Motion includes articles by Prof. em. Richard Herrmann, MD, moderated presentations by PD Jeroen S. Goede, MD, Head of Hematology (Head of the Center for Lymphomas and Leukemias), Michael Gregor, MD, Head of Hematology (Lucerne Cantonal Hospital) and Prof. Thorsten Zenz, MD, Head of the Center for Hematology and Oncology (University Hospital Zurich)…. This content can only be access by registered users. Log In Register